Events

Analytica Anacon India 2007 focusses on Hyderabad

After Mumbai and Bangalore, the fourth edition of Analytica Anacon India 2007 shifts its focus to Hyderabad, the fastest growing pharma destination in India. The city is considered the bulk drug capital of India, accounting for one third of the country's production of bulk drugs, according to Sonia Prashar, General Manager, Indo-German Chamber of Commerce (IGCC). The exhibition is being organized by Munich International Trade Fairs (MMG), Internationaler Messe-und Ausstellungsdienst GmbH (IMAG), Indian Analytical Instruments Association (IAIA) & IGCC.

Although Western India still leads the industry, the Southern region is fast catching up. The pharma industry in Hyderabad and nearby cities is worth $1 billion with an annual growth rate of 20%. Southern India comprising Bangalore, Chennai and Hyderabad has the largest biotech cluster in the country with 46% share of the total number of biotech companies in India, whereas the Western India region accounts for 48% of the total biotech revenues.

With some 150 exhibitors from eight countries and 2,700 expected guests, Analytica Anacon India is expected to cross its 2006 figures of 130 exhibitors and 2,592 visitors. When it opens its gates at its new location in the Hitex Exhibition Center in Hyderabad from October 31 to November 2, visitors will find innovations as well as several new products and systems that will meet the needs of the Indian market. Analytica Anacon India is a trade show for the global industry. According to Hans-Joachim Heusler, MD, Munich International Trade Fairs, about half of the approximately 150 expected exhibitors are globally active companies and non-Indian manufacturers.

Analytical instruments are one of the most important assets of any pharma company, biotech sectors, clinical research, environmental protection and even universities. It has a prominent place where quality is a major concern. With India's pharma market growing rapidly, there's an ever increasing need for medical and laboratory technology equipments. The market for analysis solutions, which is currently estimated to be worth Rs.20 billion is expected to grow at a rate of between 15 and 20 percent during the next few years. An enormous push is expected between now and 2010, especially in biotechnology and the life sciences. According to ASSOCHAM, the Indian biotech industry generated $1.5 billion in sales last year and are expected to reach $5 billion by 2010, says Dr. Ramakrishnan, President, Indian Analytical Instruments Association.